Skip to main content
. 2024 Jul 16;40:100818. doi: 10.1016/j.bbih.2024.100818

Table 2.

Results of mixed effects models.


Positive vaccine mindset
Vaccine efficacy mindset
Vaccine body-response mindset
Vaccine side effects mindset
Outcome β SE p β SE p β SE p β SE p
Antibody response 0.06 0.04 0.126 0.05 0.03 0.116 0.05 0.03 0.058 0.05 0.02 0.021
Side effects −0.20 0.06 <0.001 −0.10 0.05 0.048 −0.16 0.04 <0.001 0.02 0.03 0.552
Vaccine-related anxiety −1.04 0.07 <0.001 −0.44 0.05 <0.001 −0.45 0.04 <0.001 −0.05 0.04 0.127
Stress −0.22 0.04 <0.001 −0.12 0.03 <0.001 −0.09 0.03 <0.001 −0.10 0.02 <0.001
Sadness −0.16 0.04 <0.001 −0.08 0.03 <0.001 −0.07 0.02 0.002 −0.04 0.02 0.022
Happiness 0.32 0.05 <0.001 0.11 0.03 0.001 0.12 0.03 <0.001 0.05 0.02 0.015

Notes: Unstandardized betas, standard error, and p values are reported for the main effects for each of the four mindsets. Mixed-effects models for antibody response controlled for timepoint (after month 1 and month 6 following the initial vaccine series), vaccine type (Janssen/Johnson & Johnson, Moderna, Pfizer/BioNTech), the timepoint by vaccine type interaction, baseline anti-spike IgG, age, sex, BMI, and smoking status. For side effects, a Poisson regression controlled for time of dose (Dose 1 vs. Dose 2), vaccine type, and optimism. For vaccine-related anxiety, a mixed-effects model was used for the time of dose (Dose 1 vs. Dose 2), vaccine type, and optimism. For general stress, sadness, and happiness across the 0–5 days, the mixed effects models controlled for interaction with day, time of dose (Dose 1 vs. Dose 2), vaccine type, time of day (morning vs. evening), and optimism. Significant findings at the p ≤ 0.05 level are bolded.